» Articles » PMID: 26724529

ApoE Knockout Rabbits: A Novel Model for the Study of Human Hyperlipidemia

Overview
Journal Atherosclerosis
Publisher Elsevier
Date 2016 Jan 3
PMID 26724529
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Rabbits are one of the best animal models for the study of hyperlipidemia and atherosclerosis. Although many transgenic rabbits have been created, the development of gene knockout (KO) rabbits has been impossible due to the lack of rabbit embryonic stem cells. We along with others recently generated KO rabbits using genome editing techniques. In the current study, we characterized the lipoprotein profiles of apoE KO rabbits on both chow and cholesterol diets and investigated their susceptibility to a diet-induced atherosclerosis.

Approach And Results: We analyzed plasma lipids and lipoproteins of apoE KO rabbits and compared them with those of wild-type rabbits. On a chow diet, homozygous (but not heterozygous) apoE KO rabbits showed mild hyperlipidemia and, when challenged with a cholesterol diet, they showed greater susceptibility to diet-induced hyperlipidemia than did the wild-type rabbits and their plasma total cholesterol levels were remarkably increased (1070 ± 61 mg/dL in apoE KO vs. 169 ± 79 mg/dL in the wild type, p < 0.001). Hyperlipidemia in apoE KO rabbits was caused by elevated remnant lipoproteins. Interestingly, increased remnant lipoproteins in apoE KO rabbits were predominated by apoB-48 and rich in both apoA-I and apoA-IV contents. Furthermore, apoE KO rabbits developed greater aortic atherosclerosis than wild-type rabbits when fed with a cholesterol diet for 10 weeks.

Conclusions: To our knowledge, this is the first report of generating KO rabbits for the study of lipid and lipoprotein metabolism. ApoE KO rabbits should be a useful model for the study of human hyperlipidemia and atherosclerosis.

Citing Articles

Enhanced atherosclerosis in apolipoprotein E knockout rabbits: role of apoB48-rich remnant lipoproteins.

Niimi M, Chen Y, Zhao H, Tang X, Matsuhisa F, Zhou H Front Cardiovasc Med. 2024; 11:1424064.

PMID: 39087075 PMC: 11288958. DOI: 10.3389/fcvm.2024.1424064.


A novel translational model of atherosclerosis, the ex vivo pump-perfused amputated human limb model.

Hartley A, Afoke J, Liu G, Owen S, Hajhosseiny R, Hassen K Sci Rep. 2024; 14(1):17244.

PMID: 39060350 PMC: 11282226. DOI: 10.1038/s41598-024-67635-0.


USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss.

Nguyen V, Song J, Prieskorn D, Zou J, Li Y, Dolan D Transl Vis Sci Technol. 2023; 12(2):26.

PMID: 36795064 PMC: 9940772. DOI: 10.1167/tvst.12.2.26.


Genome Editing in Dyslipidemia and Atherosclerosis.

Chen Z, Lehertshuber C, Schunkert H Adv Exp Med Biol. 2022; 1396:139-156.

PMID: 36454465 DOI: 10.1007/978-981-19-5642-3_10.


Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.

Kamato D, Ilyas I, Xu S, Little P Int J Mol Sci. 2022; 23(21).

PMID: 36361754 PMC: 9656683. DOI: 10.3390/ijms232112964.